(Q71069369)
Statements
Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study (English)
Currie JL
Blessing JA
McGehee R
scientific article published on 01 April 1996